Table 3 All grade 3 and 4 toxicities
From: Phase I study of nab-paclitaxel, gemcitabine, and bevacizumab in patients with advanced cancers
Toxicity | Grade | No. of patients (%) |
|---|---|---|
Neutropenia | 3 | 19 (18) |
4 | 7 (6) | |
Fatigue | 3 | 8 (7) |
Thrombocytopenia | 4 | 3 (3) |
3 | 6 (5) | |
Infection | 3 | 7 (6) |
Nausea | 3 | 6 (5) |
Diarrhoea | 3 | 2 (2) |
Lymphedema | 3 | 1 (1) |
Dysphagia | 3 | 1 (1) |
Dyspnea | 3 | 2 (2) |
GI bleed | 3 | 3 (3) |
2 | 1 (1) | |
Anaemia | 3 | 4 (4) |
Fever | 3 | 3 (3) |
2 | 1 (1) | |
Hypotension | 3 | 2 (2) |
Abdominal pain | 3 | 2 (2) |
2 | 1 (1) | |
Dysphagia | 3 | 2 (2) |
